Up until three decades ago, obsessive-compulsive disorder (OCD) was deemed treatment resistant—an incurable and chronic disease. However, advent of specific behavioral techniques and new pharmacological agents (serotonin reuptake inhibitors) has altered this course and brought effective relief for many OCD patients. Nonetheless, a substantial number of individuals with OCD are treatment resistant and an even greater number refuse treatment or drop out prematurely. The cognitive-behavioral treatment of a 39-year-old male with OCD is described in this case study. Motivational interviewing (MI) techniques were integrated into treatment to increase adherence, particularly exposure exercises. Frequency and duration of compulsive behaviors were measured over the course of treatment and standard assessment measures were used to assess the severity of OCD symptoms. At posttreatment and follow-up a clinically significant improvement was demonstrated for OCD symptoms. Implications of these data are reviewed, and recommendations about inclusion of MI techniques for clinicians who intend on treating OCD are provided.
Abramowitz, J. ( 1997). Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 65, 44-52.
2.
Abramowitz, J. ( 2008). Obsessive compulsive disorder. In J. Hunsley & E. J. Marsh (Eds.), A guide to assessments that work (pp. 275-292). New York: Oxford University Press.
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
4.
Antony, M.M., Bieling, P.J., Cox, B.J., Enns, M.W., & Swinson, R.P. ( 1998). Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales (DASS) in clinical groups and a community sample. Psychological Assessment, 10, 176-181.
5.
Baer, L., & Minichiello, W.E. (1990). Behavior therapy for OCD . In M. A. Jenike, L. Baer, & W. E. Minichiello (Eds.), Obsessive-compulsive disorders: Theory and management (2nd ed., pp. 203-232). Chicago: Year Book Publishing.
6.
Ball, S.G., Baer, L., & Otto, M.W. ( 1996). Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: A quantitative review. Behaviour Research and Therapy, 34, 47-51.
7.
Brown, T.A., Korotitsch, W., Chorpita, B.F., & Barlow, D.H. ( 1997). Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behaviour Research and Therapy, 35, 79-89.
8.
Buckner, J.D., & Schmidt, N.B. ( 2009). A randomized pilot study of motivation enhancement therapy to increase utilization of cognitive-behavioral therapy for social anxiety . Behaviour Research and Therapy, 47, 710-715.
9.
Cottraux, J., Note, I., Yao, S.N., Lafont, S., Note, B., Mollard, E., . . . Dartigues, J.F. (2001). A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychotherapy and Psychosomatics, 70, 288-297.
10.
Dougherty, D.D., Rauch, S.L., & Jenike, M.A., (2002). Pharmacological treatments of obsessive compulsive disorder. In P. E. Nathan & J. M. Corman (Eds.), A guide to treatments that work. New York: Oxford University Press.
11.
Foa, E.B., Huppert, J.D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P.M. (2002). The Obsessive-Compulsive Inventory: Development and validation of a short version. Psychological Assessment, 14, 485-495.
12.
Franklin, M.E., & Foa, E.B. ( 1998). Cognitive-behavioral treatments for obsessive-compulsive disorder. In P. E. Nathan & J. M. Gorman (Eds.), A Guide to Treatments That Work. New York: Oxford University Press.
13.
Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleischmann, R.L., Hill, C.L., . . . Charney, D.S. ( 1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
14.
Jenike, M.A. ( 2004). Obsessive-compulsive disorder. New England Journal of Medicine, 350, 259-265.
15.
Karno, M., Golding, J.M., Sorenson, S.B., & Burnam, M.A. ( 1988). The epidemiology of obsessive-compulsive disorder in five US communities. Archive of General Psychiatry, 45, 1094-1099.
16.
Kessler, R.C., MeGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., . . . Kendler, K.S. ( 1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the national comorbidity survey . Archives of General Psychiatry, 51, 8-19.
17.
Lopez, A.D., & Murray, C.C. ( 1998). The global burden of disease, 1990-2020. Nature Medicine, 4, 1241-1243.
18.
Lovibond, S.H., & Lovibond, P.F. (1995). Manual for the Depression Anxiety Stress Scales (2nd. ed.). Sydney, Australia: Psychology Foundation.
19.
Maltby, N., & Tolin, D.F. ( 2003). Overview of treatment for OCD and spectrum conditions: Conceptualization, theory and practice. Brief Treatment and Crisis Intervention, 3, 127-144.
20.
Maltby, N., & Tolin, D.F. ( 2005). A brief motivational intervention for treatment-refusing OCD patients. Cognitive Behaviour Therapy, 34, 176-184.
21.
March, J. S., Frances, A., Kahn, D. A., & Carpenter, D. (Eds.). (1997). The expert consensus guidelines: Treatment of obsessive-compulsive disorder . Journal of Clinical Psychiatry, 58 (Suppl. 4), 1-72.
22.
Miller, W.R., & Rollnick, S. ( 2002). Motivational Interviewing: Preparing People for Change . New York, NY: Guilford.
23.
Norton, P.J. ( 2007). Depression Anxiety and Stress Scales (DASS): Psychometric analysis across four racial groups. Anxiety, Stress, and Coping: An International Journal, 20, 253-265.
24.
van Oppen, P., de Haan, E., van Balkom, A.J.L.M., Spinhoven, P., Hoogduin, K., & van Dyck, R. ( 1995). Cognitive therapy and exposure in vivo in the treatment of obsessive-compulsive disorder. Behaviour Research and Therapy , 32, 79-87.
25.
O’Sullivan, G., Noshirvani, H., Marks, I., Monteiro, W., & Lelliott, P. ( 1991). Six-year follow-up after exposure and clomipramine therapy for obsessive-compulsive disorder. Journal of Clinical Psychiatry , 52, 150-155.
26.
Pato, M.T., Zohar-Kadouch, R., Zohar, J., & Murphy, D.L. ( 1988). Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. American Journal of Psychiatry, 145, 1521-1525.
27.
Slagle, D.M., & Gray, M.J. ( 2007). The utility of motivational interviewing as an adjunct or exposure therapy in the treatment of anxiety disorders. Professional Psychology: Research and Practice, 38, 329-337.
28.
Spitzer, R.L., Gibbon, M., & Williams, J.B.W. (1996). Structured clinical interview for DSM-IV Axis I disorders. New York: New York State Psychiatric Institute, Biometrics Research Department.
29.
Wegner, D., Schneider, D., Carter, S., & White, T. ( 1987). Paradoxical effects of thought suppression. Journal of Personality and Social Psychology, 53, 5-13.
30.
Weissman, M.M., Bland, R.C., Canino, G.J., Greenwald, S., Hwu, H.G., Lee, C.K., . . . Wickramaratne, P.J., et al. (1994). The cross-national epidemiology of obsessive compulsive disorder: The cross national collaborative group. Journal of Clinical Psychiatry, 55 (Suppl. 3), 5-10.
31.
Westra, H.A. ( 2004). Managing resistance in cognitive behavioural therapy: The application of motivational interviewing in mixed anxiety and depression . Cognitive Behaviour Therapy, 33, 161-175.
32.
Wilhelm, S., & Steketee, G.S. (2006). Cognitive therapy for obsessive compulsive disorder: A guide for professionals. Oakland, CA: New Harbinger Publications.
33.
Wilhelm, S., Steketee, G., Reilly-Harrington, N., Deckersbach, T., Buhlmann, U., & Baer, L. ( 2005). Effectiveness of cognitive therapy for obsessive-compulsive disorder: An open trial. Journal of Cognitive Psychotherapy , 19, 173-179.
34.
Woody, S.R., Steketee, G., & Chambless, D.L. (1995). Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale. Behaviour Research and Therapy, 33, 597-605.
35.
Zanarini, M.C., Skodol, A.E., Bender, D., Dolan, R., Sanislow, C., Schaefer, E., . . . Gunderson, J.G. (2000). The collaborative longitudinal personality disorders study: Reliability of axis I and II diagnoses. Journal of Personality Disorders, 14, 291-299.
